BioXmark, bladder safety and performance trial
Recruiting
- Conditions
- Muscle invasive bladder cancer
- Registration Number
- NL-OMON23138
- Lead Sponsor
- Amsterdam UMC location AMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
•Patients with histologically proven primary bladder cancer
•Referred for bladder conserving (chemo-)radiotherapy
Exclusion Criteria
•Any contraindication for an cystoscopic procedure
•Pregnant women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of BioXmark liquid fiducial markers which are visible and remain in a stable position from the CT acquisition for RT planning to last CBCT <br /><br>Number of adverse events potentially associated with application of BioXmark liquid fiducial markers
- Secondary Outcome Measures
Name Time Method •Percentage of markers lost from injection to the CT acquisition for RT planning<br /><br>•Percentage of patients in which markers can be used for target delineation<br /><br>•Percentage of patients in which markers can be used for patient set-up